Meta-Analysis of Randomized Controlled Trials of Statins Versus Placebo in Patients With Heart Failure
Publication year: 2009
Source: The American Journal of Cardiology, Volume 104, Issue 12, 15 December 2009, Pages 1708-1716
Michael J., Lipinski , Clay A., Cauthen , Giuseppe G.L., Biondi-Zoccai , Antonio, Abbate , Bojan, Vrtovec , …
Although statins have been shown to improve outcomes in retrospective analyses of patients with heart failure (HF), recent randomized placebo-controlled trials have shown mixed results. The goal of this study was to systematically review randomized trials comparing statins to placebo for HF and compare the impact of different statins. CENTRAL, mRCT, and PubMed were searched for eligible studies that prospectively randomized patients with HF to statins or placebo. Primary end points were all-cause mortality, cardiovascular mortality, hospitalization for worsening HF, adverse drug events, and changes in left ventricular ejection fraction (LVEF). Pooling was performed with random effect methods with summary…
Similar Posts:
- Meta-analysis: incidence of endoscopic gastric and duodenal ulcers in placebo arms of randomized placebo-controlled NSAID trials
- Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebo-controlled trials.
- Statin treatment after a recent TIA or stroke: is effectiveness shown in randomized clinical trials also observed in everyday clinical practice?
- Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
- Multiple micronutrient supplementation for improving cognitive performance in children: systematic review of randomized controlled trials.
- Acupuncture for Alcohol Dependence: A Systematic Review
- Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials.
- Quantifying the effect of intraocular pressure reduction on the occurrence of glaucoma
- Fever is associated with doubling of odds of short-term mortality in ischemic stroke: an updated meta-analysis
- Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study